Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Fu, Xiaoyan ^a   Ju, Jiyu ^a   Lin, Zhijuan ^a   Xiao, Weiling ^a   Li, Xiaofang ^a   Zhuang, Baoxiang ^a   Zhang, Tingting ^a   Ma, Xiaojun ^a   Li, Xiangyu ^a   Ma, Chao ^a   Su, Weiliang ^a   Wang, Yuqi ^a   Qin, Xuebin ^b   Liang, Shujuan ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT; COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX; INFLAMMASOME; LIPOPOLYSACCHARIDE;

ANIMAL; CELL MEMBRANE; CHEMICALLY INDUCED; CHEMISTRY; ERYTHROCYTE; GENETICS; HEMOLYSIS; HUMAN; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SHOCK;

ANIMALS; ANTIBODIES; CELL MEMBRANE; COMPLEMENT C5B; COMPLEMENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; ERYTHROCYTES; HEMOLYSIS; HUMANS; INFLAMMASOMES; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; SHOCK;

EID: 84979287790     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30239     Document Type: Article

References (58)

1. Liu, F., Dai, S., Gordon, J., Qin, X. Complement and HIV-I infection/HIV-associated neurocognitive disorders. Journal of neurovirology 20, 184-198, doi: 10.1007/s13365-014-0243-9 (2014).
2. Morgan, B. P., Harris, C. L. Complement Regulatory Proteins. (Academic Press, 1999).
3. Walport, M. J. Complement. First of two parts. The New England journal of medicine 344, 1058-1066 (2001).
4. Walport, M. J. Complement. Second of two parts. The New England journal of medicine 344, 1140-1144 (2001).
5. Morgan, B. P. Regulation of the complement membrane attack pathway. Crit Rev Immunol 19, 173-198 (1999).
6. Medof, M. E. et al. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proceedings of the National Academy of Sciences of the United States of America 84, 2007-2011 (1987).
7. Brodbeck, W. G., Mold, C., Atkinson, J. P., Medof, M. E. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack. J Immunol 165, 3999-4006 (2000).
8. Qin, X. et al. Generation and phenotyping of mCd59a and mCd59b double-knockout mice. American journal of hematology 84, 65-70, doi: 10.1002/ajh.21319 (2009).
9. Holt, D. S. et al. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98, 442-449 (2001).
10. Miwa, T., Zhou, L., Hilliard, B., Molina, H., Song, W. C. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99, 3707-3716 (2002).
11. Wetsel, R. A., Fleischer, D. T., Haviland, D. L. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5?-exon. The Journal of biological chemistry 265, 2435-2440 (1990).
12. Bhole, D., Stahl, G. L. Molecular basis for complement component 6 (C6) deficiency in rats and mice. Immunobiology 209, 559-568 (2004).
13. Morgan, B. P. The membrane attack complex as an inflammatory trigger. Immunobiology, doi: 10.1016/j.imbio.2015.04.006 (2015).
14. Niculescu, F., Rus, H. The role of complement activation in atherosclerosis. Immunol Res 30, 73-80 (2004).
15. Benzaquen, L. R., Nicholson-Weller, A., Halperin, J. A. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. The Journal of experimental medicine 179, 985-992 (1994).
16. Nicholson-Weller, A., Halperin, J. A. Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res 12, 244-257 (1993).
17. Laudisi, F. et al. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1beta release. J Immunol 191, 1006-1010, doi: 10.4049/jimmunol.1300489 (2013).
18. Samstad, E. O. et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol 192, 2837-2845, doi: 10.4049/jimmunol.1302484 (2014).
19. Niculescu, F., Rus, H. Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells. Immunol Res 24, 191-199 (2001).
20. Cheng, K. H., Wiedmer, T., Sims, P. J. Fluorescence resonance energy transfer study of the associative state of membrane-bound complexes of complement proteins C5b-8. J Immunol 135, 459-464 (1985).
21. Morgan, B. P., Imagawa, D. K., Dankert, J. R., Ramm, L. E. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis. J Immunol 136, 3402-3406 (1986).
22. Zhou, X., Hu, W., Qin, X. The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy. The oncologist 13, 954-966, doi: 10.1634/theoncologist.2008-0089 (2008).
23. Sekar, A. et al. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177-183, doi: 10.1038/nature16549 (2016).
24. Li, Y., Lin, F. Mesenchymal stem cells are injured by complement after their contact with serum. Blood 120, 3436-3443, doi: 10.1182/blood-2012-03-420612 (2012).
25. Qin, X., Gao, B. The complement system in liver diseases. Cellular & molecular immunology 3, 333-340 (2006).
26. Powell, M. B., Marchbank, K. J., Rushmere, N. K., van den Berg, C. W., Morgan, B. P. Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59. Journal of immunology 158, 1692-1702 (1997).
27. Qin, X. et al. Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility. Immunity 18, 217-227 (2003).
28. Cohen, J. The immunopathogenesis of sepsis. Nature 420, 885-891, doi: 10.1038/nature01326 (2002).
29. Marshall, J. C. Sepsis: rethinking the approach to clinical research. Journal of leukocyte biology 83, 471-482, doi: 10.1189/jlb.0607380 (2008).
30. Rittirsch, D., Flierl, M. A., Ward, P. A. Harmful molecular mechanisms in sepsis. Nature reviews. Immunology 8, 776-787, doi: 10.1038/nri2402 (2008).
31. Mollnes, T. E., Christiansen, D., Brekke, O. L., Espevik, T. Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Advances in experimental medicine and biology 632, 253-263 (2008).
32. Franchi, L., Eigenbrod, T., Munoz-Planillo, R., Nunez, G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nature immunology 10, 241-247, doi: 10.1038/ni.1703 (2009).
33. Martinon, F., Mayor, A., Tschopp, J. The inflammasomes: guardians of the body. Annual review of immunology 27, 229-265, doi: 10.1146/annurev.immunol.021908.132715 (2009).
34. Gicquel, T. et al. IL-1beta production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages. Faseb J 29, 4162-4173, doi: 10.1096/fj.14-267393 (2015).
35. Joshi, V. D., Kalvakolanu, D. V., Hebel, J. R., Hasday, J. D., Cross, A. S. Role of caspase 1 in murine antibacterial host defenses and lethal endotoxemia. Infection and immunity 70, 6896-6903 (2002).
36. Boost, K. A. et al. Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia. Intensive care medicine 33, 863-871, doi: 10.1007/s00134-007-0588-0 (2007).
37. Morgan, B. P. Effects of the membrane attack complex of complement on nucleated cells. Current topics in microbiology and immunology 178, 115-140 (1992).
38. Morgan, B. P. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. The Biochemical journal 264, 1-14 (1989).
39. Cole, D. S., Morgan, B. P. Beyond lysis: how complement influences cell fate. Clinical science 104, 455-466, doi: 10.1042/CS20020362 (2003).
40. Lueck, K. et al. Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration. Eye 25, 1074-1082, doi: 10.1038/eye.2011.109 (2011).
41. Zhang, J. et al. Sublytic C5b-9 induces IL-6 and TGF-beta1 production by glomerular mesangial cells in rat Thy-1 nephritis through p300-mediated C/EBPbeta acetylation. FASEB J 28, 1511-1525, doi: 10.1096/fj.13-242693 (2014).
42. Yang, C., Yang, L., Liu, Y. Soluble complement complex C5b-9 promotes microglia activation. Journal of neuroimmunology 267, 16-19, doi: 10.1016/j.jneuroim.2013.11.007 (2014).
43. Triantafilou, K., Hughes, T. R., Triantafilou, M., Morgan, B. P. The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation. Journal of cell science 126, 2903-2913, doi: 10.1242/jcs.124388 (2013).
44. Takano, T., Elimam, H., Cybulsky, A. V. Complement-mediated cellular injury. Seminars in nephrology 33, 586-601, doi: 10.1016/j. semnephrol.2013.08.009 (2013).
45. Papadimitriou, J. C., Drachenberg, C. B., Shin, M. L., Trump, B. F. Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury. Virchows Archiv: an international journal of pathology 424, 677-685 (1994).
46. Fine, D. P., Gewurz, H., Griffiss, M., Lint, T. F. Meningococcal meningitis in a women with inherited deficiency of the ninth component of complement. Clinical immunology and immunopathology 28, 413-417 (1983).
47. Figueroa, J. E., Densen, P. Infectious diseases associated with complement deficiencies. Clinical microbiology reviews 4, 359-395 (1991).
48. Fasano, M. B., Densen, P., McLean, R. H., Winkelstein, J. A. Prevalence of homozygous C4B deficiency in patients with deficiencies of terminal complement components and meningococcemia. The Journal of infectious diseases 162, 1220-1221 (1990).
49. Buckingham, S. C., Ramos, T. N., Barnum, S. R. Complement C5-deficient mice are protected from seizures in experimental cerebral malaria. Epilepsia 55, e139-e142, doi: 10.1111/epi.12858 (2014).
50. Pavlovski, D. et al. Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. FASEB J 26, 3680-3690, doi: 10.1096/fj.11-202382 (2012).
51. Zhou, W. et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. The Journal of clinical investigation 105, 1363-1371, doi: 10.1172/JCI8621 (2000).
52. Lewis, R. D., Jackson, C. L., Morgan, B. P., Hughes, T. R. The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice. Molecular immunology 47, 1098-1105, doi: 10.1016/j.molimm.2009.10.035 (2010).
53. Carrera-Marin, A. et al. C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies. Lupus 21, 1497-1505, doi: 10.1177/0961203312458839 (2012).
54. Wu, G. et al. Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice. Circulation 121, 1338-1346 (2010).
55. Wu, G. et al. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex. Circulation research 104, 550-558, doi: CIRCRESAHA.108.191361 (2009).
56. Liu, F. et al. Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice. Atherosclerosis 234, 237-243, doi: 10.1016/j.atherosclerosis.2014.03.004 (2014).
57. Yun, S., Leung, V. W., Botto, M., Boyle, J. J., Haskard, D. O. Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59. Arteriosclerosis, thrombosis, and vascular biology 28, 1714-1716, doi: ATVBAHA.108.169912 (2008).
58. An, G. et al. CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice. Molecular immunology 46, 1702-1709, doi: S0161-5890(09)00075-3 (2009).